When a company develops a new drug it is awarded a patent, giving it exclusive rights to sell the medicine and recoup the expense of coming up with it. In theory when the patent expires and any company that chooses can produce the drug, prices should come down. The manufacture of so called generic drugs has been encouraged in the United States as a free-market alterntive to the European system of governments negotiating with drug companies to control prices.